US delays ruling on Roche drugUS regulators have extended by three months a review of Roche Holding's blockbuster drug Avastin in breast cancer, the company said. The Food and Drug Administration has made no decision on whether to revoke Avastin's approval for More… |
US rejects experimental painkillerUS government advisers have urged regulators to reject an experimental painkiller from King Pharmaceuticals and Acura Pharmaceuticals. The Acurox pill was designed to discourage abuse by adding the vitamin niacin to the painkiller oxycodon More… |








